The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Year to date metric has recorded a gain of 20.78%.However, over the last six months, we can see a weaker performance of 10.34%. Over the last 30 days, the price of RXRX has fallen by 14.52%. And in the last five days, it has surged by 10.49%.
Recursion Pharmaceuticals Inc had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $15.74 on 02/27/24, while the lowest price during the same period was $5.60 on 11/22/24.
52-week price history of RXRX Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Recursion Pharmaceuticals Inc’s current trading price is -48.13% away from its 52-week high, while its distance from the 52-week low is 45.80%. The stock’s price range for this period has been between $5.60 and $15.74. The Healthcare sector company’s shares saw a trading volume of about 16.24 million for the day, which was higher than the average daily volume of 10.47 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Recursion Pharmaceuticals Inc (RXRX) has experienced a quarterly rise of 33.63% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.45B.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 6.79, with a change in price of +1.70. Similarly, Recursion Pharmaceuticals Inc recorded 8,548,595 in trading volume during the last 100 days, posting a change of +26.04%.
RXRX’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for RXRX stands at 0.17. Similarly, the long-term debt-to-equity ratio is also 0.14.
RXRX Stock Stochastic Average
As of today, the raw stochastic average of Recursion Pharmaceuticals Inc over the past 50 days is 66.91%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 63.89%. Additionally, the Stochastic %K and %D values for the company were 50.30% and 38.01%, respectively, over the past 20 days.
